May 29, 2023 — Expert opinion holds that ultra-processed food is not a good thing. So it’s quite natural to expect that helping people resist the convenience and taste of this ubiquitous type of food will help with dietary health outcomes. So natural that it’s quite easy to dismiss inconvenient, unexpected findings. A little ultra-processing of study results in […]
March 29, 2023 — Scientists and regulators at the FDA have identified a critical gap in new drug development and labeling. It is the failure to test new drugs in people with obesity. Where there are differences in clinical responses and safety, labeling – the instructions for safe use – should reflect those differences. But in many cases, they […]
October 20, 2021 — Day by day, the prospects for treating obesity are getting better. Late on Monday, detailed results from the longest study yet of tirzepatide came out in Lancet. This was a study using this new drug in people with type 2 diabetes, but the average BMI of these patients was 33. None of them had a […]
